Isolation and Structural Characterization of Degradation Products of Aceclofenac by HPLC, HRMS and 2D NMR

Author:

Guduru Santhosh1,Karun Mutha V.V.S.R.N. Anji1,Vijayabhaskar B.2,Kaliyaperumal Muralidharan2,Korupolu Raghu Babu3,Bonige Kishore Babu3,Rumalla Chidananda Swamy2

Affiliation:

1. Department of Medicinal Chemistry, GVK Biosciences Pvt. Ltd, IDA Mallapur, Hyderabad-500076, India; Department of Engineering Chemistry, Andhra University, Visakhapatnam-530003, India

2. Department of Medicinal Chemistry, GVK Biosciences Pvt. Ltd, IDA Mallapur, Hyderabad-500076, India

3. Department of Engineering Chemistry, Andhra University, Visakhapatnam-530003, India

Abstract

The stability of aceclofenac under stress conditions was assessed to identify the degradation products. So, it was subjected to stress conditions like acid, base and oxidation, according to ICH guideline Q1A (R2). One degradation product formed when the drug was subjected to acid stress. Three degradation products were formed during the basic stress condition. The drug substance was found to be stable to oxidative stress. The degradants formed during the stress were separated on a C-18 column using gradient preparative HPLC elution. The only product (DP-2) formed during the acid stress and this one is same as of one of the three degradation products (DP-1, DP-2, DP-3) were formed during base stress. 1D and 2D NMR spectra and mass spectral analysis supported the proposed structures for the products. The products DP-2 and DP-3 have been reported earlier but this is the first report of product DP-1 as a degradation product of aceclofenac.

Publisher

Asian Journal of Chemistry

Subject

General Chemistry

Reference15 articles.

1. H.P. Rang, J.M. Ritter, R.J. Flower, G. Henderson and M.M. Dale, Rang and Dale’s Pharmacology, Elsevier: Churchill Livingstone (2016).

2. The role of dipeptidylpeptidase IV positive T cells in wound healing and angiogenesis

3. Effects of Aceclofenac and Diclofenac on Synovial Inflammatory Factors in Human Osteoarthritis

4. R. Yamazaki, S. Kawai, T. Matsuzaki, N. Kaneda, S. Hashimoto, T. Yokokura and R. Okamoto, J. Pharmacol. Exp. Ther., 28, 676 (1999).

5. International Conference on Harmonization, Q1A (R2) Stability Testing of New Drug Substances and Products, International Conference on Harmonization, IFPMA: Geneva (2003).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3